Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Eosinophil diversity in asthma.
Biochem Pharmacol. 2020 Sep;179:113963. doi: 10.1016/j.bcp.2020.113963. Epub 2020 Apr 8.
Biochem Pharmacol. 2020.
PMID: 32278006
Review.
Eosinophils as Drivers of Severe Eosinophilic Asthma: Endotypes or Plasticity?
Van Hulst G, Bureau F, Desmet CJ.
Van Hulst G, et al.
Int J Mol Sci. 2021 Sep 21;22(18):10150. doi: 10.3390/ijms221810150.
Int J Mol Sci. 2021.
PMID: 34576313
Free PMC article.
Review.
Item in Clipboard
Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma.
Van Hulst G, Jorssen J, Jacobs N, Henket M, Louis R, Schleich F, Bureau F, Desmet CJ.
Van Hulst G, et al.
Eur Respir J. 2022 Mar 17;59(3):2100935. doi: 10.1183/13993003.00935-2021. Print 2022 Mar.
Eur Respir J. 2022.
PMID: 34475229
Free article.
Item in Clipboard
Reply: Ex vivo SOCS3 gene responsiveness to alarmins in eosinophils of mepolizumab-treated patients is as yet of unknown biological significance.
Van Hulst G, Jorssen J, Jacobs N, Henket M, Louis R, Schleich F, Bureau F, Desmet CJ.
Van Hulst G, et al.
Eur Respir J. 2022 Jul 21;60(1):2200981. doi: 10.1183/13993003.00981-2022. Print 2022 Jul.
Eur Respir J. 2022.
PMID: 35777778
Free article.
No abstract available.
Item in Clipboard
Cite
Cite